Analysts are intrested in these 5 stocks: ( (HUBS) ), ( (ATRA) ), ( (UPWK) ), ( (FSLY) ) and ( (PLNT) ). Here is a breakdown of their recent ratings and the rationale behind them.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
HubSpot is suddenly on the defensive as three high‑profile analysts step back from their earlier bullish stance. Arjun Bhatia, Matthew Vanvliet and Tyler Radke all downgraded HUBS to Hold or Neutral after a mixed first quarter and a softer outlook for 2026. They point to slower net new ARR growth, elongated sales cycles and a disruptive sales retraining tied to new AI products that temporarily cut sales capacity.
While revenue is still growing around 18% in constant currency and valuation looks inexpensive at roughly 10x free cash flow, these experts see rising execution risk and less visibility on a near‑term growth reacceleration. Pricing tailwinds and AI credit consumption help, but are not yet enough to flip sentiment in a software sector where investors now demand clear, accelerating trends before rewarding stocks.
Atara Biotherapeutics, by contrast, is back on investors’ radar after a key regulatory meeting changed the narrative around its lead therapy, tab‑cel. Analyst John Newman upgraded ATRA to Buy and doubled his price target to $13, arguing the FDA now appears open to approving the single‑arm Phase 3 ALLELE study using a historical control, rather than insisting on an impractical randomized trial in this ultra‑orphan setting.
Tab‑cel already has approval in the EU, and if the U.S. follows, Atara would unlock a $31 million milestone payment plus future milestones and double‑digit royalties, extending its cash runway beyond 2026. Newman lifted the probability of success for tab‑cel from 30% to 65%, seeing potential for Atara to restart its allogeneic CAR‑T programs if cash inflows materialize as hoped.
Freelance platform Upwork faces a tougher road as macro headwinds and AI pressures collide with its long‑term growth story. Analyst Maria Ripps cut her rating from Buy to Hold and slashed the price target to $10 after a mixed first quarter marked by flat gross services volume, softer revenue guidance and shrinking active clients, even as margins surged on aggressive cost cuts.
Management is leaning on a 24% workforce reduction and expects to hit its 35% adjusted EBITDA margin target more than two years early, but visibility on a revenue reacceleration remains low. With around 10% of GSV in AI‑at‑risk categories and customers increasingly citing AI as a substitute for smaller contracts, Ripps sees limited near‑term catalysts, even though a modest demand recovery could quickly re‑rate the stock from today’s low multiples.
Fastly, on the other hand, just earned a fresh vote of confidence from Raymond James, which upgraded the edge cloud and content delivery player to Outperform. Analyst Frank Louthan believes the recent post‑earnings selloff has gone too far, arguing that operational improvements, not hype, are driving better results, and that the company is positioned to capture growing AI‑related traffic thanks to its more advanced network and security capabilities.
At about 4.5x estimated 2027 EV/revenue, Fastly trades close to peer Akamai, yet Louthan sees enough upside to justify a $23 price target based on 5.5x 2027 revenue of roughly $799 million. He contends that as AI and inference workloads expand, sophisticated CDNs like Fastly’s—embedded in major interconnected data centers—should gain share over do‑it‑yourself solutions, making the current pullback an attractive entry point.
Planet Fitness rounds out the list with a trio of downgrades as its high‑growth image takes a hit. Analysts Andrew Didora, Max Rakhlenko and Stephen Grambling all moved to neutral stances, cutting price targets into the $47–59 range after management reset its 2026 outlook and scrapped a planned Black Card price increase to avoid scaring off value‑conscious members.
Weak first‑quarter sign‑ups in the key membership season, marketing missteps that missed beginners, rising competition and concerns about saturation in mature gyms all contribute to a more cautious stance. While analysts still see Planet Fitness as a strong brand in an attractive industry, they warn that new marketing campaigns and strategic tweaks may not show results until 2027, leaving shares likely range‑bound as investors wait for clear evidence of a successful turnaround.

